BACKGROUND AND OBJECTIVES: Sixteen laboratories from 10 different countries participated in an international collaborative study to evaluate candidate materials as the first World Health Organization (WHO) International Standard for hepatitis A virus (HAV) RNA nucleic acid amplification technology (NAT) assays. MATERIALS AND METHODS: Five candidate materials were analysed in this study: materials AA and BB were lyophilized, while materials CC, DD and EE were liquid preparations. Samples were diluted in pooled plasma or in pooled cryo-poor plasma (sample EE). Serial dilutions of the candidate materials were tested by each laboratory in four independent assays and the results were analysed statistically. RESULTS: The mean log(10)'equivalents' per ml were 5.29 for sample AA, 5.07 for sample BB, 4.99 for sample CC, 5.40 for sample DD and 4.08 for sample EE. CONCLUSIONS: Based on the results of this study, sample AA was established as the first International Standard for HAV RNA NAT assays at the WHO Expert Committee on Biological Standardizaton (ECBS) meeting held in February 2003. The code number of this preparation is 00/560 and the potency, based on the study, is 100 000 International Units (IU)/ml.
BACKGROUND AND OBJECTIVES: Sixteen laboratories from 10 different countries participated in an international collaborative study to evaluate candidate materials as the first World Health Organization (WHO) International Standard for hepatitis A virus (HAV) RNA nucleic acid amplification technology (NAT) assays. MATERIALS AND METHODS: Five candidate materials were analysed in this study: materials AA and BB were lyophilized, while materials CC, DD and EE were liquid preparations. Samples were diluted in pooled plasma or in pooled cryo-poor plasma (sample EE). Serial dilutions of the candidate materials were tested by each laboratory in four independent assays and the results were analysed statistically. RESULTS: The mean log(10)'equivalents' per ml were 5.29 for sample AA, 5.07 for sample BB, 4.99 for sample CC, 5.40 for sample DD and 4.08 for sample EE. CONCLUSIONS: Based on the results of this study, sample AA was established as the first International Standard for HAV RNA NAT assays at the WHO Expert Committee on Biological Standardizaton (ECBS) meeting held in February 2003. The code number of this preparation is 00/560 and the potency, based on the study, is 100 000 International Units (IU)/ml.
Authors: Roberta M Madej; Jack Davis; Marcia J Holden; Stan Kwang; Emmanuel Labourier; George J Schneider Journal: J Mol Diagn Date: 2010-01-14 Impact factor: 5.568
Authors: R T Hayden; K M Hokanson; S B Pounds; M J Bankowski; S W Belzer; J Carr; D Diorio; M S Forman; Y Joshi; D Hillyard; R L Hodinka; M N Nikiforova; C A Romain; J Stevenson; A Valsamakis; H H Balfour Journal: J Clin Microbiol Date: 2007-11-07 Impact factor: 5.948
Authors: Suely Gonçalves Cordeiro da Silva; Luciane Almeida Amado Leon; Gilda Alves; Selma Magalhães Brito; Valcieny de Souza Sandes; Magda Maria Adorno Ferreira Lima; Marta Colares Nogueira; Rita de Cássia Barbosa da Silva Tavares; Jane Dobbin; Alexandre Apa; Vanessa Salete de Paula; Jaqueline Mendes de Oliveira Oliveira; Marcelo Alves Pinto; Orlando da Costa Ferreira; Iara de Jesus Ferreira Motta Journal: Transfus Med Hemother Date: 2015-11-24 Impact factor: 3.747
Authors: J J Wenzel; M Schemmerer; H Oberkofler; H Kerschner; P Sinha; C Koidl; F Allerberger Journal: Food Environ Virol Date: 2014-09-03 Impact factor: 2.778
Authors: Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway Journal: BioDrugs Date: 2005 Impact factor: 5.807